Both in Pharmaceuticals
Polaryx Therapeutics vs Rallybio
Over the past year PLYX returned −94.9% and RLYB returned +199.3%; their daily moves had a correlation of -0.04.
PLYX −94.9% RLYB +199.3%Growth of $1, one year, split-adjusted
| Metric | PLYX | RLYB |
|---|---|---|
| Price | $1.80 | $15.71 |
| Market cap | $89.7M | $84.6M |
| Today | +4.05% | −0.98% |
| 1 month | −14.3% | −8.1% |
| 6 months | −52.6% | +7.9% |
| Year to date | — | +186.1% |
| 1 year | — | +193.8% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 3.2× |
| Price / sales | — | 194.8× |
| Net cash | $11.5M | $90.7M |
| Dividend yield | — | — |
| Volatility (60d) | 68.1% | 23.8% |
| Short % of float | 0.8% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).